Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "8"

News & Events

Child Health Research Seminars March 2013

The Kids for Child Health Research presents seminars from our leading researchers every Friday. They are designed to inform both the scientific co

Research

A systematic review on the impact of delayed local therapy in patients with Ewing sarcoma of the pelvis

Local treatment of pelvic Ewing Sarcoma (EWS) is czhallenging due to complex anatomy and potential complications. Local therapy may be deferred to maintain chemotherapy dose-intensity, but the impact of this delay on outcomes remains unclear.

Research

Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells

Tumor cell death potentially engages with the immune system. However, the efficacy of anti-tumor chemotherapy may be limited by tumor-driven...

News & Events

West Coast Cancer Meeting 2025

Join us as WA’s cancer research community comes together at the inaugural West Coast Cancer Meeting.

News & Events

New Study: Self Compassion for young people

Study: Self-Compassion for Young People with Type 1 Diabetes PARTICIPANTS NEEDED:  We are looking for young Australians 14-17 years with type 1

News & Events

Meeting with families in China

Prof Helen Leonard and Dr Jenny Downs recently visited Shenzhen, China to meet Chinese families and child neurologists from the Shenzhen Children's Hospital.

Secret Agent Society

This small group program helps children crack the code of emotions and friendships through an animated ‘secret agent’ theme.

Research

Australia-wide point prevalence survey of antimicrobial prescribing in neonatal units: How much and how good?

This is the first Australia-wide point prevalence survey of neonatal antimicrobial prescribing in tertiary children's hospitals.

Research

N-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease

Reducing oxidative stress, could modify telomere erosion during cell replication, and cardiovascular disease risk in patients with chronic kidney disease

Research

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types

We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types.